These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28757271)

  • 1. Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
    Mishra P; Florian J; Peter J; Vainorius M; Fried MW; Nelson DR; Birnkrant D
    Gastroenterology; 2017 Sep; 153(3):626-631. PubMed ID: 28757271
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
    Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin and chronic hepatitis C infection.
    FDA Consum; 2001; 35(5):3. PubMed ID: 11697089
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
    Sockalingam S; Sheehan K; Feld JJ; Shah H
    Am J Psychiatry; 2015 Jun; 172(6):512-6. PubMed ID: 26029803
    [No Abstract]   [Full Text] [Related]  

  • 5. A major advance in treating hepatitis C.
    Johns Hopkins Med Lett Health After 50; 2011 Dec; 23(10):6. PubMed ID: 22216468
    [No Abstract]   [Full Text] [Related]  

  • 6. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pegasys: FDA approved Pegasys (peginterferon alfa-2a) for the treatment of hepatitis C].
    Iafolla M
    Sidahora; 2002; (4):8-10. PubMed ID: 12703472
    [No Abstract]   [Full Text] [Related]  

  • 8. Ribavirin approved for hepatitis C combination treatment.
    James JS
    AIDS Treat News; 1998 Jun; (No 297):7. PubMed ID: 11365595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Childs-Kean LM; Hong J
    Gastroenterology; 2017 Oct; 153(4):1165-1166. PubMed ID: 28881195
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy.
    Smith MA; Love BL; Mohammad RA
    Expert Opin Drug Saf; 2015; 14(11):1649-52. PubMed ID: 26365685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
    Sherman KE; Fleischer R; Laessig K; Murray J; Tauber W; Birnkrant D;
    Hepatology; 2007 Dec; 46(6):2014-20. PubMed ID: 18027878
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA's meeting of Antiviral Drugs Advisory Committee.
    AIDS Alert; 2006 Oct; 21(10):118-9. PubMed ID: 17063593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis C: current therapy].
    Moradpour D; Müllhaupt B
    Rev Med Suisse; 2015 Apr; 11(471):902-6. PubMed ID: 26072595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hepatitis C treatment uptake in the United States.
    Clark PJ; Thompson AJ; Patel K; Muir AJ; Volk ML
    Hepatology; 2014 Aug; 60(2):768-9. PubMed ID: 24944012
    [No Abstract]   [Full Text] [Related]  

  • 16. [Direct-acting antiviral treatment of chronic hepatitis C infection].
    Grüner N; Gerbes A
    MMW Fortschr Med; 2015 Apr; 157(8):57-60. PubMed ID: 26012687
    [No Abstract]   [Full Text] [Related]  

  • 17. Telaprevir: a hepatitis C NS3/4A protease inhibitor.
    Matthews SJ; Lancaster JW
    Clin Ther; 2012 Sep; 34(9):1857-82. PubMed ID: 22951253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complete atrio-ventricular block: a rare complication of interferon alpha therapy].
    Roche NC; Paule P; Kerebel S; Gil JM; Heno P; Fourcade L
    Presse Med; 2011 Mar; 40(3):316-8. PubMed ID: 21242049
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
    Price JC; Terrault NA
    Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approves Hep C drugs.
    AIDS Alert; 2004 Jun; 19(6):71. PubMed ID: 15272452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.